N@N

Gary Nachman Maintained (ALNY) at Hold with Increased Target to $196 on, Aug 27th, 2021

Gary Nachman of BMO Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Increased Target from $174 to $196 on, Aug 27th, 2021.

Gary has made no other calls on ALNY in the last 4 months.

There are 4 other peers that have a rating on ALNY. Out of the 4 peers that are also analyzing ALNY, 1 agrees with Gary's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Edward Tenthoff of "Piper Sandler" Downgraded from Buy to Hold and Held Target at $181 on, Wednesday, August 4th, 2021

These are the ratings of the 3 analyists that currently disagree with Gary

---

• Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $250 on, Friday, August 13th, 2021
• David Lebovitz of "Morgan Stanley" Maintained at Buy with Increased Target to $234 on, Wednesday, August 4th, 2021
• Gena Wang of "Barclays" Maintained at Buy with Increased Target to $216 on, Wednesday, August 4th, 2021

Contributing Sources

---